Individuals often rely on the advice of more experienced peers to minimise uncertainty and increase success likelihood. In most domains where knowledge is acquired through experience, advisers are themselves continuously learning. Here we examine the way advising behaviour changes throughout the learning process, and the way individual traits and costs and benefits of giving advice shape this behaviour. We ran a series of experiments implementing a decision task within a reinforcement learning framework, where participants could decide to share their choices as advice to others. Participants were overall likely to share their choices as advice, even on the first trial before learning. Tendency to share advice and advice quality increased as advisers learned about the value of choices, and moved from exploratory to exploitative behaviour. The introduction of consequences to advising resulted in a shift of the overall tendency to give advice, lowering it when advising implicated monetary loss, and increasing it when advising held reputational value. Individual differences in social anxiety levels were associated with lower tendency to share exploratory decisions. Our results show that advisers tend to share choices that are backed by their own experience, but that this relationship can be altered by advice-consequences and individual traits.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11659411PMC
http://dx.doi.org/10.1038/s44271-024-00175-5DOI Listing

Publication Analysis

Top Keywords

share choices
12
individual traits
8
choices advice
8
tendency share
8
advice
7
share
5
experience advice
4
advice consequences
4
consequences shape
4
shape sharing
4

Similar Publications

Objective: Digital therapeutics (DTx) are promising technologies. However, current assessment and access frameworks, when they exist, are heterogeneous and fragmented. We analysed and compared health technology assessment (HTA) criteria for DTx across European countries that had assessed the same DTx products.

View Article and Find Full Text PDF

Background: The evolving healthcare landscape emphasizes the need for health systems to adapt to growing complexities, with new models of care enabling healthcare providers to optimize their scope of practice and coordination of care. Despite increasing interest in advanced practice, confusion persists regarding the roles and scopes of practice of healthcare providers, exacerbated by variations in regulations and titles. We sought to clarify the differences between specialized healthcare professionals, practitioners, and clinical specialists; to describe their roles; and to propose initiatives aimed at supporting the implementation of advanced practice within a university hospital.

View Article and Find Full Text PDF

Predicting changes in agricultural yields under climate change scenarios and their implications for global food security.

Sci Rep

January 2025

School of BioSciences, Centre of Excellence for Biosecurity Risk Analysis, University of Melbourne, Melbourne, 3010, Australia.

Climate change has direct impacts on current and future agricultural productivity. Statistical meta-analysis models can be used to generate expectations of crop yield responses to climatic factors by pooling data from controlled experiments. However, methodological challenges in performing these meta-analyses, together with combined uncertainty from various sources, make it difficult to validate model results.

View Article and Find Full Text PDF

Crossmodal correspondences, or widely shared tendencies for mapping experiences across sensory domains, are revealed in common descriptors of musical timbre such as , , and . Two experiments are reported in which participants listened to recordings of musical instruments playing major scales, selected colors to match the timbres, and rated the timbres on crossmodal semantic scales. Experiment A used three different keyboard instruments, each played in three pitch registers.

View Article and Find Full Text PDF

Background: Tecovirimat, an antiviral treatment for smallpox, was approved as a treatment for mpox by the European Medicines Agency in January 2022. Approval was granted under "exceptional circumstances" based on effectiveness found in pre-clinical challenge studies in animals and safety studies in humans showing minimal side effects. As clinical efficacy studies are still ongoing, there is currently limited information with regard to the acceptability of tecovirimat to treat mpox.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!